4:48 PM
Sep 05, 2013
 |  BC Extra  |  Financial News

Cubist raises $700 million in note deal

Cubist Pharmaceuticals Inc. (NASDAQ:CBST) raised $700 million through the sale of convertible senior unsecured notes to institutional investors to fund its acquisition of infectious disease company Optimer Pharmaceuticals Inc. (NASDAQ:OPTR)....

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >